JMCR: Clinical Reasoning from Case Reports
Published in Biomedical Research
The Clinical Problem
A 25-year-old woman had experienced severe hypertension for five years.
Despite treatment with amlodipine, valsartan, and hydrochlorothiazide, her blood pressure remained between 160/100 and 180/110 mmHg, with tachycardia exceeding 130 beats per minute.
Her clinical course included:
- two late pregnancy losses;
- a third-trimester stillbirth associated with preeclampsia;
- a transient ischemic attack two years before the current evaluation; and
- severe concentric left-ventricular hypertrophy.
Previous evaluation for secondary hypertension had included 24-hour urinary vanillylmandelic acid and metanephrines and an adrenal-focused CT scan. These investigations had been interpreted as normal.
The negative results appeared reassuring.
The clinical phenotype was not.
Clinical Reasoning: Step 1
Start with the age and severity of hypertension
Severe resistant hypertension in a woman in her early twenties is not typical essential hypertension until important secondary causes have been considered.
The initial differential includes:
- renal parenchymal disease;
- renal-artery stenosis, including fibromuscular dysplasia;
- primary aldosteronism;
- thyroid disease;
- Cushing syndrome;
- medication or substance exposure;
- pheochromocytoma or paraganglioma; and
- less common vascular or endocrine disorders.
The question is not whether every young patient with hypertension has an endocrine tumor. It is whether the full phenotype fits ordinary hypertension well enough to stop investigating.
Here, it did not.
Pause and consider
Which features most strongly increase suspicion for catecholamine excess?
The combination of severe resistant hypertension, marked tachycardia, headache, palpitations, and facial flushing is substantially more suggestive than hypertension alone.
Clinical Reasoning: Step 2
Complications are clues, not separate problems
Three adverse pregnancy outcomes, a transient ischemic attack, and left-ventricular hypertrophy could each be managed as separate consequences of hypertension.
Placed together, however, they indicate prolonged and physiologically important blood-pressure instability.
Pregnancy can amplify the danger of an unrecognized catecholamine-secreting tumor. Maternal and fetal complications may result from severe vasoconstriction, hypertensive crises, arrhythmia, placental hypoperfusion, and cardiovascular stress.
The report does not prove that the paraganglioma caused each pregnancy loss; fetal autopsy and placental pathology were not available. Nevertheless, the obstetric history materially increases the importance of explaining the severe hypertension.
Clinical pearl
When one diagnosis could connect several apparently separate complications, revisit the unifying mechanism before accepting multiple unrelated explanations.
Clinical Reasoning: Step 3
How much reassurance should a negative test provide?
The original 24-hour urinary testing was reported as normal, but the numerical results were unavailable. The report also lacked documentation of specimen completeness, acidification, refrigeration, dietary preparation, or medication adjustment.
Those limitations matter.
A negative biochemical result reduces diagnostic probability only to the extent that:
- the correct analytes were measured;
- the specimen was collected and handled correctly;
- interfering drugs, foods, and physiological stressors were considered;
- the tumor was secreting enough catecholamine metabolite to be detected; and
- the pretest probability was appropriately incorporated.
Vanillylmandelic acid is also generally less sensitive than fractionated metanephrine testing.
Pause and consider
What should be done when an earlier negative result conflicts with a persistent high-probability phenotype?
Review the original method and preanalytical conditions, then repeat testing under controlled conditions using an appropriate contemporary assay.
Clinical Reasoning: Step 4
Repeat biochemical evaluation
Before repeat testing, the patient followed a three-day low-catecholamine diet and underwent medication adjustment. The 24-hour urine collection was documented as complete, properly acidified, and refrigerated.
Results showed:
- urinary normetanephrine: 1855.8 µg/24 hours, with an upper reference limit of 600;
- plasma free normetanephrine: 672 pg/mL, with an upper reference limit of 180.
These concordant abnormalities transformed the diagnostic probability.
The next task was localization.
Clinical Reasoning: Step 5
Look beyond the adrenal glands
The earlier CT examination had been adrenal-focused and interpreted as normal.
A subsequent abdominal CT angiogram demonstrated a 45.6 × 29.2 mm retroperitoneal mass posterior to the pancreas and anterior to the aorta.
This location is crucial. A normal-appearing adrenal gland does not exclude a functional paraganglioma because paragangliomas arise outside the adrenal medulla.
Clinical pearl
The anatomical field of an imaging study must match the biological possibilities. “Normal adrenal imaging” and “no pheochromocytoma–paraganglioma” are not equivalent statements.
The Diagnostic Pivot
The diagnostic pivot was the decision to distrust a discordant negative result.
The patient’s young age, resistant hypertension, tachycardia, episodic headache, palpitations, flushing, pregnancy complications, transient ischemic attack, and left-ventricular hypertrophy created a high-probability illness script.
Repeat metanephrine testing under controlled conditions and imaging extending beyond the adrenal glands then revealed the biochemical and anatomical diagnosis.
What Was the Final Diagnosis?
A functional retroperitoneal paraganglioma causing prolonged catecholamine-associated hypertension.
After sequential alpha- and beta-adrenergic blockade and volume expansion, the mass was completely excised.
Microscopy demonstrated nests of polygonal cells with granular cytoplasm in a characteristic Zellballen arrangement, supporting paraganglioma. Immunohistochemical confirmation could not be performed because of local resource limitations.
Postoperatively, the patient’s blood pressure rapidly normalized without antihypertensive medication. During eight years of follow-up, she remained asymptomatic, with normal blood pressure and urinary catecholamine measurements and no imaging evidence of recurrence.
Formal germline testing was not available. This remains an important limitation because contemporary evaluation of pheochromocytoma–paraganglioma commonly includes assessment for hereditary susceptibility.
Differential Diagnosis at the Critical Decision Point
1. Essential hypertension
Essential hypertension is common, but the patient’s age, resistance to three medications, tachycardia, paroxysmal symptoms, and accumulated end-organ and obstetric complications made this diagnosis insufficient without a renewed secondary evaluation.
2. Renovascular hypertension
Fibromuscular dysplasia is an important consideration in a young woman. The available abdominal vascular imaging did not support renal-artery disease.
3. Primary aldosteronism
Resistant hypertension warrants consideration of primary aldosteronism. The report did not identify hypokalemia or other biochemical evidence supporting it, although absence of hypokalemia alone would not exclude the disorder.
4. Thyroid disease
A palpable thyroid was noted, but thyroid disease did not account for the complete biochemical and imaging pattern.
5. Pheochromocytoma
The symptoms and catecholamine excess were compatible with pheochromocytoma, but the tumor was extra-adrenal.
6. Functional paraganglioma
The elevated normetanephrines, extra-adrenal retroperitoneal mass, catecholamine-associated symptoms, histological Zellballen architecture, and postoperative normalization of blood pressure supported this diagnosis.
Why This Case Matters
The central lesson is not that negative tests are untrustworthy. It is that a test result must be interpreted in relation to the method, specimen quality, disease biology, and pretest probability.
A false sense of closure may develop when “normal metanephrines” or “normal adrenal CT” is copied forward without reviewing what was measured, how the specimen was handled, or whether extra-adrenal disease was considered.
This patient’s clinical trajectory shows the potential cost of that closure: prolonged severe hypertension, pregnancy losses, cerebrovascular symptoms, and cardiac remodeling.
Clinical Pearls
- Severe hypertension in a young adult warrants a structured secondary evaluation.
- Headache, palpitations, flushing, and tachycardia increase suspicion for catecholamine excess.
- Obstetric complications may be a major clue to an undiagnosed hypertensive endocrine disorder.
- Negative biochemical testing should be revisited when specimen conditions are uncertain.
- Fractionated metanephrines are more informative than relying on vanillylmandelic acid alone.
- Normal adrenal imaging does not exclude an extra-adrenal paraganglioma.
- Biochemical evidence should generally guide anatomical localization.
- Alpha blockade should precede beta blockade before resection of a functional tumor.
- Histology supports the diagnosis, but contemporary evaluation should include appropriate immunohistochemistry when available.
- Genetic assessment should be considered even when syndromic features and family history are absent.
Potential Pitfalls
Pitfall 1: Treating one negative result as permanent exclusion
Better approach: Reassess the test method, specimen conditions, disease probability, and whether repeat testing is justified.
Pitfall 2: Equating normal adrenal imaging with exclusion of the entire PPGL spectrum
Better approach: Remember that paragangliomas are extra-adrenal and may require broader anatomical imaging.
Pitfall 3: Fragmenting the complications
Better approach: Ask whether pregnancy loss, TIA, cardiac hypertrophy, tachycardia, and resistant hypertension share a single pathophysiological explanation.
Pitfall 4: Beginning beta blockade first
Better approach: In a functional catecholamine-secreting tumor, establish adequate alpha blockade before adding beta blockade to avoid unopposed alpha-adrenergic vasoconstriction.
Pitfall 5: Claiming causation beyond the evidence
Better approach: The tumor provides a plausible unifying mechanism, but the report cannot prove that it caused every pregnancy loss because placental and fetal pathological information was unavailable.
Clinical Timeline
| Time | Clinical development |
|---|---|
| Five-year period | Severe hypertension persists despite three medications |
| During this period | Two late pregnancy losses and one third-trimester stillbirth associated with preeclampsia |
| Two years before definitive evaluation | Transient ischemic attack without lasting deficit |
| Initial secondary workup | Urinary VMA/metanephrines and adrenal-focused CT interpreted as normal |
| Definitive presentation | BP 160/100–180/110 mmHg, tachycardia, headache, palpitations, flushing, paresthesia |
| Repeat testing | Markedly elevated urinary and plasma normetanephrine after controlled preparation |
| Localization | CT angiography reveals retroperitoneal mass posterior to pancreas and anterior to aorta |
| Treatment | Alpha blockade, subsequent beta blockade, volume expansion, and complete excision |
| Pathology | Zellballen architecture consistent with paraganglioma |
| Postoperative course | Blood pressure normalizes without medication |
| Eight-year follow-up | No reported biochemical or imaging evidence of recurrence |
Five Questions for the Reader
Question 1
Which feature most strongly argues against accepting essential hypertension without further investigation?
A. Age 25 years with hypertension resistant to three medications
B. Absence of a family history
C. Palpable thyroid
D. Previous normal brain CT
E. Generalized paresthesia
Answer: A
Rationale: Severe resistant hypertension at a young age substantially increases the probability of a secondary cause.
Question 2
What is the best response to the previously normal urinary study?
A. Permanently exclude catecholamine-secreting tumors
B. Repeat VMA without reviewing collection conditions
C. Review the original method and repeat appropriate metanephrine testing under controlled conditions
D. Proceed directly to adrenalectomy
E. Diagnose panic disorder
Answer: C
Rationale: The original values and preanalytical conditions were unavailable. Persistent high clinical suspicion justified properly controlled repeat testing.
Question 3
Why did the previous adrenal-focused CT not exclude the final diagnosis?
A. Paragangliomas are always microscopic
B. Paragangliomas may arise outside the adrenal glands
C. CT cannot demonstrate retroperitoneal tumors
D. The tumor developed only after the scan
E. All paragangliomas arise in the neck
Answer: B
Rationale: Extra-adrenal paragangliomas may lie outside the anatomical scope or interpretive focus of adrenal imaging.
Question 4
Which preoperative sequence is appropriate for a functional paraganglioma?
A. Beta blockade followed by alpha blockade
B. Alpha blockade followed by beta blockade when needed
C. Beta blockade alone
D. Diuresis followed by fluid restriction
E. Immediate biopsy without preparation
Answer: B
Rationale: Alpha blockade should precede beta blockade to avoid unopposed alpha-adrenergic stimulation.
Question 5
Which statement best captures the diagnostic lesson?
A. Negative tests are never useful
B. Every pregnancy loss is caused by paraganglioma
C. Test results must be interpreted in relation to pretest probability and preanalytical quality
D. Histology is unnecessary when blood pressure improves
E. Normal adrenal imaging excludes all catecholamine-secreting tumors
Answer: C
Rationale: The diagnosis was delayed because discordant negative investigations were given more weight than the persistent high-risk clinical phenotype.
Clinical Take-Home Message
In a young patient with severe resistant hypertension, tachycardia, episodic adrenergic symptoms, pregnancy complications, or premature cardiovascular and cerebrovascular injury, a previous negative evaluation should not end the investigation when the phenotype remains strongly suggestive of catecholamine excess.
Review what was measured, how the specimen was collected and handled, and whether imaging covered extra-adrenal locations.
A negative test should modify probability—not silence continuing clinical evidence.
Journal of Medical Case Reports is the world’s first international, PubMed-listed medical journal devoted to publishing case reports from all medical disciplines and will consider any original case report that expands the field of general medical knowledge, and original research relating to case reports. The journal is open access and strongly endorses the CARE guidelines for case reports, requiring authors to submit populated CARE checklists with submissions to improve transparency in reporting.
Based on: Al Darra A, Kahal F, Katt N, Abbas B. A 5-year delayed paraganglioma diagnosis: three pregnancy losses and a TIA following false-negative testing—a case report. Journal of Medical Case Reports. 2026.
DOI: 10.1186/s13256-026-06789-z
AI disclosure: Artificial intelligence tools were used to assist with drafting, language editing and generating the accompanying illustrations. The author reviewed and edited the content, verified the clinical information against the cited publications, and takes full responsibility for the final post.
Follow the Topic
-
Journal of Medical Case Reports
This journal will consider any original case report that expands the field of general medical knowledge, and original research relating to case reports.